The Atlantic :press: on Nostr: The Future of Ozempic Will Be Riddled With Dupes Obesity-drug shortages have led to a ...
Published at
2024-08-16 15:43:04Event JSON
{
"id": "d6c93915db7643ba5293b43bf68fd11215a5bfc388216edc74df5cf8b4ac59d5",
"pubkey": "736ac37ea560e091b7bd858c82be3f252cf024d94d579cd5bda142134abeb2c1",
"created_at": 1723822984,
"kind": 1,
"tags": [
[
"t",
"press"
],
[
"proxy",
"https://press.coop/users/TheAtlantic/statuses/112972463121668242",
"activitypub"
]
],
"content": "The Future of Ozempic Will Be Riddled With Dupes\n\nObesity-drug shortages have led to a boom in risky alternatives. They may be impossible to stop. #press\n\nhttps://www.theatlantic.com/health/archive/2024/08/future-ozempic-will-be-riddled-dupes/679484/?utm_source=press.coop\n\nhttps://cdn.theatlantic.com/thumbor/rsjQU4fUbCDJP6bsJ3UBLF4fIUk=/media/img/mt/2024/08/ozempic_copycats/original.jpg",
"sig": "762aa40aa8bcb48dbf96da168f096abf8e53f541288a8aa486c3033220a19aac61c793a549b11c32d515f8b74c5717e8b4a64a73bc554cd1a0128206d2d7937f"
}